Measuring inconsistency in meta-analyses

By Julian P. T. Higgins, S. Thompson, J. Deeks, Douglas G. Altman. British medical journal, 2003

57,483 citations recorded by the source corpus.

Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice? Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis. Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4 Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted? A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …

Subfields: Critical Care and Intensive Care Medicine, General Health Professions, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/bef40c4e1347f940e8f3d420e24d9a070863e8d9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

  1. Georgia Salanti
  2. John P. A. Ioannidis
  3. S. Jak
  4. S. Fazel
  5. C. D’Arcy
  6. Xiangfei Meng
  7. D. A. Cook
  8. A. Ford

In General Health Professions

  1. David Moher
  2. Douglas G. Altman
  3. Georgia Salanti
  4. John P. A. Ioannidis
  5. P. Erwin
  6. D. A. Cook
  7. Mike Clarke
  8. Julian P. T. Higgins

In Statistics and Probability

  1. John P. A. Ioannidis
  2. David Moher
  3. Douglas G. Altman
  4. Julian P. T. Higgins
  5. Georgia Salanti
  6. Ian R. White
  7. R. Riley
  8. Haitao Chu

Citations in the corpus